• About Us
  • Contact Us
  • Today Headline
  • Write for us
Today Headline
No Result
View All Result
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
No Result
View All Result
TodayHeadline
No Result
View All Result

3 takeaways ahead of potential fall Covid booster campaign

April 7, 2022
in Health News
Reading Time: 3 mins read
virus outbreak vaccines 32979 – TodayHeadline



virus outbreak vaccines 32979 – TodayHeadline

The meeting came just days after the FDA and the CDC endorsed making second boosters available for Americans over 50 and certain immunocompromised patients. But a senior FDA official insisted that was intended as a stopgap to offer older populations an option while the federal government deliberates how to approach Covid vaccination moving forward, even as the virus mutates.

The panel ended its day with expectations of another meeting to be scheduled by early summer and without a firm framework to guide booster policy in the interim. Here are the biggest takeaways from the daylong meeting:

Manufacturers need to launch trials soon

Given the novelty of the coronavirus and the array of technologies used in developing the vaccines, the FDA needs manufacturers to provide clinical trial data to support changes to their formulation, officials said during the meeting. That’s unlike the flu vaccine, which is annually updated after consultations at the World Health Organization and within the FDA based on the latest data on circulating variants.

If vaccine makers aren’t close to launching trials by early May, getting enough product to meet a fall immunization goal “would be a pretty difficult thing to do, I think,” said Robert Johnson, director of the medical countermeasures program at HHS’ Biomedical Advanced Research and Development Authority.

Peter Marks, FDA’s top vaccine regulator, later suggested a “May-to-June timeframe” is feasible to get trials of reformulated Covid jabs off the ground.

“There is probably some wiggle room,” he said. “That’s not a lot more time, but it’s a little bit more time.”

What effectiveness level is acceptable?

Committee members stressed that the decision-making process should also consider the protection threshold for opting for a new vaccine composition instead of relying on the current formulas, which are based on the virus’ original strain.

While efficacy against infection has waned over time for all three vaccines available in the U.S., protection against severe disease, hospitalization and death has largely held up, members noted, especially among healthy and younger populations. But scientists have yet to coalesce around so-called correlates of protection — the level at which a body’s immune response from antibodies and memory cells provides adequate protection against the virus — relying instead on neutralizing antibody titers that soar post-immunization and then ebb over time.

“We know what kind of antibody response can be generated,” said panel member Eric Rubin of the Harvard T.H. Chan School of Public Health. “We just don’t know if it works.”

Federal officials acknowledged a need to reach a consensus around a vaccine efficacy level against severe disease that advisers feel comfortable with, since both zero infection and perpetual boosters are unsustainable. Marks said he’s concerned about vaccine fatigue among the public absent a more concrete booster strategy.

“As we come into the November timeframe, that may be the time to try to boost again if the committee is in agreement in order to protect against a wave that could come at the highest time that we are at risk for respiratory viruses, going inside again,” he said.

The great unknown

Panel members agreed that myriad unknowns persist about the coronavirus and how it might evolve.

It’s more likely that variants will continue to emerge from Omicron’s lineage, said Trevor Bedford, who works on coronavirus evolutionary forecasting at the Fred Hutchinson Cancer Research Center. But it’s also possible that another, fundamentally different strain evolves — much like Omicron did — that stresses the ability of vaccines and past infection to protect people from disease.

“This virus isn’t flu,” said Paul Offit of the Children’s Hospital of Philadelphia.

  • Trending
  • Comments
  • Latest
How science class can inspire students to explore inequities in – TodayHeadline

How science class can inspire students to explore inequities in their communities

Cutest puppies Featured – TodayHeadline

31 Dog Breeds That Have The CUTEST Puppies Ever

Can you buy Robert Krafts blue pin Stand Up To – TodayHeadline

Can you buy Robert Kraft’s blue pin? Stand Up To Jewish Hate campaign launches

56534965 10712627 Johnny Depp s sister Christi Dembrowski 61 took the stand in his a 56 1649797714609 – TodayHeadline

Johnny Depp gets emotional as his sister testifies about abusive childhood

mary j blige wants to play nina simone in biopic 1200x675 – TodayHeadline

Mary J. Blige Wants To Play Nina Simone In Biopic

1680135305 social – TodayHeadline

Howard Schultz tells Bernie Sanders that Starbucks ‘doesn’t need a union’

Adam Peaty to miss British championships due to mental health | Adam Peaty

gettyimages 1342295960 wide 2481e9ea9fcffe21ff238da67f2fc61e9cc603e8 s1400 c100 – TodayHeadline

FDA mulls COVID booster for 65 and older plus immunocompromised : Shots

PopularStories

mary j blige wants to play nina simone in biopic 1200x675 – TodayHeadline
Entertainment News

Mary J. Blige Wants To Play Nina Simone In Biopic

1680135305 social – TodayHeadline
Business news

Howard Schultz tells Bernie Sanders that Starbucks ‘doesn’t need a union’

Sports

Adam Peaty to miss British championships due to mental health | Adam Peaty

gettyimages 1342295960 wide 2481e9ea9fcffe21ff238da67f2fc61e9cc603e8 s1400 c100 – TodayHeadline
Health News

FDA mulls COVID booster for 65 and older plus immunocompromised : Shots

About Us

Todayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.

Follow Us

Latest News

mary j blige wants to play nina simone in biopic 1200x675 – TodayHeadline

Mary J. Blige Wants To Play Nina Simone In Biopic

1680135305 social – TodayHeadline

Howard Schultz tells Bernie Sanders that Starbucks ‘doesn’t need a union’

Adam Peaty to miss British championships due to mental health | Adam Peaty

mary j blige wants to play nina simone in biopic 1200x675 – TodayHeadline

Mary J. Blige Wants To Play Nina Simone In Biopic

1680135305 social – TodayHeadline

Howard Schultz tells Bernie Sanders that Starbucks ‘doesn’t need a union’

Adam Peaty to miss British championships due to mental health | Adam Peaty

  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline

No Result
View All Result
  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.